NCT02737800View on ClinicalTrials.gov

Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Endometrioma
Interventions
PROCEDURE

endometrioma aspiration

Transvaginal ultrasound guided aspiration

DRUG

GnRh agonist ( Decapeptyl )

3 monthly doses of Decapeptyl 7.5mg intramuscular

PROCEDURE

standard long stimulation protocol

Decapeptyl 3.75mg in the mid luteal phase followed by human menopausal gonadotropins(HMG);fostimon, or merional injections after bleeding, doses are individualization according to each patient, monitored by follicular size \&serum estradiol.

Trial Locations (1)

Unknown

Kasrelaini Hospital, Giza

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT02737800 - Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients | Biotech Hunter | Biotech Hunter